BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20039304)

  • 1. The A2aR adenosine receptor controls cytokine production in iNKT cells.
    Nowak M; Lynch L; Yue S; Ohta A; Sitkovsky M; Balk SP; Exley MA
    Eur J Immunol; 2010 Mar; 40(3):682-7. PubMed ID: 20039304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Mehta CK; Kron IL; Laubach VE
    Am J Respir Crit Care Med; 2016 May; 193(9):988-99. PubMed ID: 26757359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular adenosine controls NKT-cell-dependent hepatitis induction.
    Subramanian M; Kini R; Madasu M; Ohta A; Nowak M; Exley M; Sitkovsky M; Ohta A
    Eur J Immunol; 2014 Apr; 44(4):1119-29. PubMed ID: 24448964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
    Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
    J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.
    van der Vliet HJ; Wang R; Yue SC; Koon HB; Balk SP; Exley MA
    J Immunol; 2008 Jun; 180(11):7287-93. PubMed ID: 18490728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo ELISpot Assay to Investigate iNKT Cell Responses in Acute Dengue Infection.
    Kamaladasa AI; Malavige GN
    Methods Mol Biol; 2018; 1808():181-186. PubMed ID: 29956184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
    Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antiinflammatory purinergic signaling in activated human iNKT cells.
    Yu JC; Lin G; Field JJ; Linden J
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
    Guan P; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.
    Field JJ; Lin G; Okam MM; Majerus E; Keefer J; Onyekwere O; Ross A; Campigotto F; Neuberg D; Linden J; Nathan DG
    Blood; 2013 Apr; 121(17):3329-34. PubMed ID: 23377438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
    Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
    J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner.
    Kim HS; Chung DH
    Mucosal Immunol; 2013 Mar; 6(2):347-57. PubMed ID: 22892939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
    Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
    J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT cells inhibit development of the Th17 lineage.
    Mars LT; Araujo L; Kerschen P; Diem S; Bourgeois E; Van LP; Carrié N; Dy M; Liblau RS; Herbelin A
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6238-43. PubMed ID: 19325124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response.
    Lee YJ; Wang H; Starrett GJ; Phuong V; Jameson SC; Hogquist KA
    Immunity; 2015 Sep; 43(3):566-78. PubMed ID: 26362265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium chloride inhibits IFN-γ, but not IL-4, production by invariant NKT cells.
    Jeong D; Kim HY; Chung DH
    J Leukoc Biol; 2018 Jan; 103(1):99-106. PubMed ID: 29345057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
    Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
    Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.